A new deal in the animal feed sector. Royal DSM, the Dutch global science-based company active in health, nutrition and materials, acquired Twilmij B.V., a well-established Dutch nutritional solutions company in the animal feed sector.
Amyris, the U.S. industrial bioscience company led by John Melo, closed the second and final tranche of its previously announced financing. The second tranche of $50 million in a private placement was led by a $25 million investment from Koninklijke DSM N.V. (Royal DSM) with the remaining $25 million contributed by Vivo Capital.
Amyris, Inc., the U.S. industrial bioscience company, and Koninklijke DSM N.V. (Royal DSM), the Dutch global science-based company active in health, nutrition and materials, have agreed for DSM to make an equity investment in Amyris. At the same time, the companies will enter into a development cooperation focused on products for the global health and nutrition markets (including vitamins and other nutritional ingredients).
Royal DSM, the global Life Sciences and Materials Sciences company headquartered in The Netherlands, announced yesterday a “substantial investment” in its Wilmington, Massachusetts (USA) manufacturing facility in order to produce waterborne resins for inks and coatings. Driven by its commitment to grow the sustainable coatings market, DSM will
upgrade its facilities to produce state-of-the-art waterborne resins for inks and coatings.
Poet-Dsm’s Project Liberty will open its doors to the public at its Grand Opening celebration on Wednesday, September 3 in Emmetsburg, Iowa, showcasing first-of-its-kind technology that is poised to dramatically expand world’s resources for transportation fuel.